251
TITLE: TIME OF OCCURRENCE OF ADVERSE EVENTS IN RELATION TO START OF TREATMENT WITH ESLICARBAZEPINE ACETATE AS ADD-ON TREATMENT IN PATIENTS WITH PARTIAL-ONSET SEIZURES  Full Text
AUTHORS: Gama, H; Elger, C; Halasz, P; Ben Menachem, E; Alain Gabbai, A; Lopes Lima, J; Gil Nagel, A; Nunes, T; Moreira, J; Mota, F; Maia, J; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2009, SOURCE: 28th International Epilespy Congress in EPILEPSIA, VOLUME: 50
INDEXED IN: WOS
252
TITLE: TOLERABILITY AND PHARMACOKINETICS OF TRANS-RESVERATROL AND ITS EFFECT ON THE LEVODOPA PHARMACOKINETICS FOLLOWING 100/25 MG LEVODOPA/BENSERAZIDE  Full Text
AUTHORS: Almeida, L; F Rocha; Falcao, A; Nunes, T; Fernandes Lopes, C; Costa, R; Loureiro, A; Soares, E; Mota, F; Wright, L; Vaz da Silva, M; Soares da Silva, P ;
PUBLISHED: 2009, SOURCE: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, VOLUME: 105
INDEXED IN: WOS
253
TITLE: Trans-resveratrol, a New Esterase Inhibitor of Eslicarbazepine Acetate Hydrolysis  Full Text
AUTHORS: Ana I Loureiro; Carlos Fernandes Lopes; Lyndon C Wright; Patricio Soares da Silva ;
PUBLISHED: 2009, SOURCE: 11th European Regional ISSX Meeting in DRUG METABOLISM REVIEWS, VOLUME: 41
INDEXED IN: WOS
254
TITLE: Unique Profile in Renal Mineralocorticoid Receptor Expression Change in Aged Spontaneously Hypertensive Rats
AUTHORS: Vanda Pinto; Sonia Simao; Elisabete Silva; Maria Joao Pinho; Pedro Gomes; Patricio Soares da Silva ;
PUBLISHED: 2009, SOURCE: 63rd High Blood Pressure Research Conference in HYPERTENSION, VOLUME: 54, ISSUE: 4
INDEXED IN: WOS
255
TITLE: A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations
AUTHORS: Ferreira, JJ; Rascol, O; Poewe, W; Sampaio, C; Rocha, F; Nunes, T; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2008, SOURCE: 12th International Congress of Parkinsons Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 23, ISSUE: 1
INDEXED IN: WOS
256
TITLE: A new approach on the purification of recombinant human soluble catechol-O-methyltransferase from an Escherichia coli extract using hydrophobic interaction chromatography  Full Text
AUTHORS: Passarinha, LA ; Bonifacio, MJ; Soares da Silva, P ; Queiroz, JA ;
PUBLISHED: 2008, SOURCE: 5th Hydrophobic Interaction Chromatography/Reversed-Phase Liquid Chromatography Bioseparation Conference (HIC/RPC) in JOURNAL OF CHROMATOGRAPHY A, VOLUME: 1177, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 20
257
TITLE: Adverse non-drug-related complaints by healthy volunteers in Phase I studies compared to the healthy general population
AUTHORS: Almeida, L; Coelho, R; Albino Teixeira, A ; Soares Da Silva, P ;
PUBLISHED: 2008, SOURCE: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, VOLUME: 46, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 4
259
TITLE: Dopamine
AUTHORS: Pedro Gomes ; Patrio Soares-da-silva ;
PUBLISHED: 2008, SOURCE: Cardiovascular Hormone Systems
INDEXED IN: CrossRef: 7
260
TITLE: Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells
AUTHORS: Li, HW; Armando, I; Yu, PY; Escano, C; Mueller, SC; Asico, L; Pascua, A; Lu, QS; Wang, XY; Villar, VM; Jones, JE; Wang, Z; Periasamy, A; Lau, YS; Soares da Silva, P ; Creswell, K; Guillemette, G; Sibley, DR; Eisner, G; Felder, RA; Jose, PA; ...More
PUBLISHED: 2008, SOURCE: JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 118, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 11
Page 26 of 75. Total results: 743.